drugset / Trial / NCT05280496

A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes

NCT05280496 ↗

Phase 3 Completed 20 enrolled Tufts Medical Center
NaSingle-groupOpen-labelPrevention

Summary

This study is testing whether daily metformin for 1 year postpartum can reduce risk of diabetes in patients who had gestational diabetes. Typical care for prediabetes after gestational diabetes is counseling on diet and lifestyle. This study is researching whether management of diabetes prevention is more effective with the drug metformin. This study will be conducted at Tufts Medical Center.

Timeline

Start
2022-06-01
Primary completion
2025-03-01
Completion
2025-04-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — —